Literature DB >> 14089298

STUDIES ON THE SITE OF ACTION OF A CIRCULATING ANTICOAGULANT IN DISSEMINATED LUPUS ERYTHEMATOSUS. EVIDENCE THAT THIS ANTICOAGULANT INHIBITS THE REACTION BETWEEN ACTIVATED STUART FACTOR (FACTOR X) AND PROACCELERIN (FACTOR V).

R T BRECKENRIDGE, O D RATNOFF.   

Abstract

Entities:  

Keywords:  ANTICOAGULANTS; BLOOD COAGULATION TESTS; ENZYME INHIBITORS; FACTOR V; FACTOR X; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROTHROMBIN

Mesh：

Substances：

Year:  1963        PMID： 14089298     DOI： 10.1016/0002-9343(63)90243-2

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  3 in total

1.  The Role of Proaccelerin in Human Blood Coagulation. Evidence that Proaccelerin Is Converted to a Prothrombin-converting Principle by Activated Stuart Factor: With Notes on the Anticoagulant Action of Soybean Trypsin Inhibitor, Protamine Sulfate, and Hexadimethrine Bromide.

Authors:  R T Breckenridge; O D Ratnoff
Journal:  J Clin Invest       Date:  1965-02       Impact factor: 14.808

2.  [Inhibitor of prothrombin activation].

Authors:  K Lechner; M Fischer; J Kühböck; C Steffen; W Waldhäusl
Journal:  Klin Wochenschr       Date:  1969-11-15

3.  The anticoagulant activity of lysosomal cationic proteins from polymorphonuclear leukocytes.

Authors:  H I Saba; H R Roberts; J C Herion
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.